Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024. [PDF]
Pharmaceuticals (Basel)Wang Z, Sun X, Sun M, Wang C, Yang L.
europepmc +1 more source
Maximizing blood pressure lowering effects: a review of drug class comparisons and rationale for combination approaches. [PDF]
Front Cardiovasc MedYang Y, Wan F, Xu J, Mei Deng H, Pan P.
europepmc +1 more source
Approaching Drug Choices and Challenges for the Management of Hypertension. [PDF]
HypertensionBress AP, Luther JM.
europepmc +1 more source
Arterial Hypertension: Novel Pharmacological Targets and Future Perspectives. [PDF]
J Clin MedPopa IP +10 more
europepmc +1 more source
Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach. [PDF]
High Blood Press Cardiovasc PrevNardoianni G +5 more
europepmc +1 more source
Research trends and performance of endothelin A receptor antagonist in kidney care: a bibliometric analysis. [PDF]
Ren FailCheungpasitporn W +7 more
europepmc +1 more source
Resistant Hypertension: Disease Burden and Emerging Treatment Options. [PDF]
Curr Hypertens RepFlack JM, Buhnerkempe MG, Moore KT.
europepmc +1 more source
Antihypertensive therapy in diabetes mellitus: efficacy, safety, and metabolic impacts in type 1 and type 2 diabetes. [PDF]
Cardiovasc Diabetol Endocrinol RepJoshi P +12 more
europepmc +1 more source
Renal Denervation for Uncontrolled Hypertension: A Measurement-First, Program-Based Approach. [PDF]
J Clin MedSzarpak L +9 more
europepmc +1 more source